13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosis

Summary Whereas intracellular carbon metabolism has emerged as an attractive drug target, the carbon sources of intracellularly replicating pathogens, such as the tuberculosis bacillus Mycobacterium tuberculosis, which causes long-term infections in one-third of the world’s population, remain mostly unknown. We used a systems-based approach—13C-flux spectral analysis (FSA) complemented with manual analysis—to measure the metabolic interaction between M. tuberculosis and its macrophage host cell. 13C-FSA analysis of experimental data showed that M. tuberculosis obtains a mixture of amino acids, C1 and C2 substrates from its host cell. We experimentally confirmed that the C1 substrate was derived from CO2. 13C labeling experiments performed on a phosphoenolpyruvate carboxykinase mutant revealed that intracellular M. tuberculosis has access to glycolytic C3 substrates. These findings provide constraints for developing novel chemotherapeutics.

[1]  G. Bancroft,et al.  Characterization of Auxotrophic Mutants ofMycobacterium tuberculosis and Their Potential as Vaccine Candidates , 2001, Infection and Immunity.

[2]  Christopher M. Sassetti,et al.  Mycobacterial persistence requires the utilization of host cholesterol , 2008, Proceedings of the National Academy of Sciences.

[3]  A. Mohan,et al.  Multidrug-resistant tuberculosis. , 2004, The Indian journal of medical research.

[4]  Sabine Ehrt,et al.  Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection , 2010, Proceedings of the National Academy of Sciences.

[5]  Parissa Farnia,et al.  Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. , 2009, Chest.

[6]  Sabine Ehrt,et al.  Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. , 2010, Chemistry & biology.

[7]  K. Kuhen,et al.  A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy , 2010, Nature Communications.

[8]  Carolyn R Bertozzi,et al.  Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. , 2012, Chemistry & biology.

[9]  Alladi Mohan,et al.  Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. , 2006, Chest.

[10]  V. Subbulakshmi,et al.  Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. , 2009, Microbiology.

[11]  E. Muñoz-Elías,et al.  Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence , 2005, Nature Medicine.

[12]  T. Weisbrod,et al.  In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis , 1995, Infection and immunity.

[13]  S. Klamt,et al.  GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism , 2007, Genome Biology.

[14]  P. Verma,et al.  Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. , 2012, Cell host & microbe.

[15]  W. Jacobs,et al.  Attenuation of and Protection Induced by a Leucine Auxotroph of Mycobacterium tuberculosis , 2000, Infection and Immunity.

[16]  B. Robertson,et al.  Mycobacterial Mutants with Defective Control of Phagosomal Acidification , 2005, PLoS pathogens.

[17]  W. Eisenreich,et al.  Isotopologue Profiling of Legionella pneumophila , 2010, The Journal of Biological Chemistry.

[18]  H. Kornfeld,et al.  THP-1 Cell Apoptosis in Response to Mycobacterial Infection , 2003, Infection and Immunity.

[19]  David G. Russell,et al.  Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress* , 2013, The Journal of Biological Chemistry.

[20]  Bernd Freisleben,et al.  Cloud MapReduce for Monte Carlo bootstrap applied to Metabolic Flux Analysis , 2013, Future Gener. Comput. Syst..

[21]  W. Eisenreich,et al.  Carbon Metabolism of Enterobacterial Human Pathogens Growing in Epithelial Colorectal Adenocarcinoma (Caco-2) Cells , 2010, PloS one.

[22]  Harold J. Morowitz,et al.  Ancient Genes in Contemporary Persistent Microbial Pathogens , 2006, The Biological Bulletin.

[23]  I. Smith,et al.  Global Transcriptional Profile of Mycobacterium tuberculosis during THP-1 Human Macrophage Infection , 2007, Infection and Immunity.

[24]  R. Brosch,et al.  Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death , 2012, PLoS pathogens.

[25]  D. Schnappinger,et al.  Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. , 2011, Cell host & microbe.

[26]  M. Horwitz,et al.  Glutamine Synthetase GlnA1 Is Essential for Growth of Mycobacterium tuberculosis in Human THP-1 Macrophages and Guinea Pigs , 2003, Infection and Immunity.

[27]  W. Jacobs,et al.  Protection Elicited by Two Glutamine Auxotrophs of Mycobacterium tuberculosis and In Vivo Growth Phenotypes of the Four Unique Glutamine Synthetase Mutants in a Murine Model , 2006, Infection and Immunity.

[28]  W Wiechert,et al.  A universal framework for 13C metabolic flux analysis. , 2001, Metabolic engineering.

[29]  Sarman Singh,et al.  Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis , 2010, Cell.

[30]  Digby F. Warner,et al.  Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during Growth on Fatty Acids , 2008, Journal of bacteriology.

[31]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[32]  S. Noack,et al.  13C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation , 2011, PLoS pathogens.

[33]  T. Dandekar,et al.  13C isotopologue perturbation studies of Listeria monocytogenes carbon metabolism and its modulation by the virulence regulator PrfA , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Wolfgang Wiechert,et al.  13CFLUX2—high-performance software suite for 13C-metabolic flux analysis , 2012, Bioinform..

[35]  Amit Singhal,et al.  Modulation of Gamma Interferon Receptor 1 by Mycobacterium tuberculosis: a Potential Immune Response Evasive Mechanism , 2007, Infection and Immunity.

[36]  Uwe Sauer,et al.  Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis , 2011, PLoS pathogens.